ArticleRespirology case reports2026
Three-Year Diagnostic Delay in Shrinking Lung Syndrome: Rituximab-Theophylline Combination as Rescue Therapy.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Suspected shrinking lung syndrome: a rare pulmonary manifestation of systemic lupus erythematosus-a case-based review of an underrecognized condition.Rheumatology international · 2026Review
- Three-Year Diagnostic Delay in Shrinking Lung Syndrome: Rituximab-Theophylline Combination as Rescue Therapy.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shrinking lung syndrome (SLS) is an infrequent complication of systemic lupus erythematosus (SLE). A 41-year-old woman with a 10-year history of SLE presented with dyspnea, chest pain, and dry cough. She had poor medication compliance and multiple hospitalizations over 3 years for similar symptoms, without a definitive diagnosis. Imaging revealed bilateral basal atelectasis and an elevated right hemidiaphragm, while pulmonary function tests (PFTs) showed a restrictive pattern. Other lung and cardiac conditions were excluded, leading to a diagnosis of SLS. Treatment with rituximab, prednisolone, and theophylline improved PFTs, chest pain, cough, and dyspnea at follow-up. Clinicians should consider SLS in SLE patients with dyspnea and characteristic imaging, as delayed diagnosis may increase morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.